Abu Dhabi-based M42 and Global Medical Supply Chain (GMSC), a subsidiary of Mubadala Bio, have signed an outsourcing agreement to strengthen medical supply chain services across M42’s healthcare network.
Signed during the Make it in the Emirates 2026, the agreement supports the UAE’s goals of localising critical industries, improving supply chain resilience, and building a future-ready healthcare ecosystem.
Under the agreement, GMSC will manage an integrated supply chain model across M42’s network, including sourcing and procurement, demand planning, warehousing, distribution, and inventory management. The partnership will cover pharmaceuticals, medical consumables, equipment, and instruments.
Click here to join our WhatsApp channel here
Dimitris Moulavasilis said the partnership strengthens M42’s ability to deliver patient-centric care while supporting the UAE’s localisation ambitions and operational efficiency goals.
Dr. Bakheet Al Katheeri, Chief Executive Officer of Mubadala’s UAE Investments platform, said: “This agreement marks a significant step forward for Mubadala in its efforts to support realising the UAE’s ambition to build a globally leading, self-sustaining healthcare and life sciences ecosystem. By uniting Mubadala Bio’s specialised capabilities with M42’s scale, we are strengthening supply chain resilience while accelerating the development of in-country capabilities that will underpin long-term national health security, industrial growth, and global competitiveness.”
Hamad Husein Al Marzooqi, Group Deputy CEO, Mubadala Bio, said: “The partnership agreement with M42 reflects Mubadala Bio’s commitment to delivering end-to-end pharmaceutical logistics across the UAE.”
The agreement is expected to improve procurement efficiency, optimise demand forecasting, enhance inventory visibility, reduce supply disruption risks, and strengthen in-country healthcare capabilities.
M42 currently operates more than 480 facilities across 26 countries and includes healthcare providers such as Cleveland Clinic Abu Dhabi, Danat Al Emarat, and Imperial College London Diabetes Centre.
Also read: Nivey Nocher Joins The PHA Group to Lead Health Department
